Biologics: Targets and Therapy

ISSN: 1177-5491

Editor-in-Chief: Professor Shein-Chung Chow

ISSN: 1177-5475 (Print) - went to online only in 2009

An international, peer reviewed journal focusing on the patho-physiological rationale for, and clinical application of, Biologic agents and their Biosimilars in the management of autoimmune diseases, cancers, or other pathologies where a molecular target can be identified.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

Articles:

Latest articles:

- 5 records -

Original Research

TNFSF13B rs9514828 C>T Polymorphism is Associated with Incidence of Atherosclerosis and Therapeutic Outcomes in Patients with Systemic Lupus Erythematosus

Fajar DR, Rostinawati T, Hamijoyo L, Sahiratmadja E, Amalia R, Barliana MI

Biologics: Targets and Therapy 2024, 18:95-106

Published Date: 3 May 2024

Review

Novel Molecular Targets in Endometrial Cancer: Mechanisms and Perspectives for Therapy

Soberanis Pina P, Lheureux S

Biologics: Targets and Therapy 2024, 18:79-93

Published Date: 21 March 2024

Review

MDMX in Cancer: A Partner of p53 and a p53-Independent Effector

Lin W, Yan Y, Huang Q, Zheng D

Biologics: Targets and Therapy 2024, 18:61-78

Published Date: 31 January 2024

Review

Advances with Platelet-Rich Plasma for Bone Healing

Bacevich BM, Smith RDJ, Reihl AM, Mazzocca AD, Hutchinson ID

Biologics: Targets and Therapy 2024, 18:29-59

Published Date: 25 January 2024

Review

Recent Advancements in Reducing the Off-Target Effect of CRISPR-Cas9 Genome Editing

Asmamaw Mengstie M, Teshome Azezew M, Asmamaw Dejenie T, Teshome AA, Tadele Admasu F, Behaile Teklemariam A, Tilahun Mulu A, Mekonnen Agidew M, Adugna DG, Geremew H, Abebe EC

Biologics: Targets and Therapy 2024, 18:21-28

Published Date: 18 January 2024